These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 24401336)

  • 61. Clinical Microbiology and Infectious Diseases--13th European Congress: anti-infectives and resistance, 10-13 May, Glasgow, UK.
    Gravenstede S
    IDrugs; 2003 Jun; 6(6):505-8. PubMed ID: 12861969
    [No Abstract]   [Full Text] [Related]  

  • 62. Joining Forces: The Chemical Biology-Medicinal Chemistry Continuum.
    Plowright AT; Ottmann C; Arkin M; Auberson YP; Timmerman H; Waldmann H
    Cell Chem Biol; 2017 Sep; 24(9):1058-1065. PubMed ID: 28602761
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Harnessing genomics in the battle against antimicrobial resistance and neglected tropical diseases.
    Dance DAB; Batty EM
    EBioMedicine; 2021 Jan; 63():103178. PubMed ID: 33340997
    [No Abstract]   [Full Text] [Related]  

  • 64. New directions in cancer research 2003: technological advances in biology, drug resistance, and molecular pharmacology.
    Franks ME; Macpherson GR; Lepper ER; Figg WD; Sparreboom A
    Drug Resist Updat; 2003 Dec; 6(6):301-12. PubMed ID: 14744494
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Antimicrobial magnetic nanoparticles based-therapies for controlling infectious diseases.
    Rodrigues GR; López-Abarrategui C; de la Serna Gómez I; Dias SC; Otero-González AJ; Franco OL
    Int J Pharm; 2019 Jan; 555():356-367. PubMed ID: 30453018
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Interscience Conference on Antimicrobial Agents and Chemotherapy--49th annual meeting. Part 1. 11-15 September 2009, San Francisco, CA, USA.
    Turner B; Murch L
    IDrugs; 2009 Nov; 12(11):667-9. PubMed ID: 19844846
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Folate biosynthesis pathway: mechanisms and insights into drug design for infectious diseases.
    Bertacine Dias MV; Santos JC; Libreros-Zúñiga GA; Ribeiro JA; Chavez-Pacheco SM
    Future Med Chem; 2018 Apr; 10(8):935-959. PubMed ID: 29629843
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Designing improved active peptides for therapeutic approaches against infectious diseases.
    Gomes B; Augusto MT; Felício MR; Hollmann A; Franco OL; Gonçalves S; Santos NC
    Biotechnol Adv; 2018; 36(2):415-429. PubMed ID: 29330093
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Nanotechnology and pulmonary delivery to overcome resistance in infectious diseases.
    Andrade F; Rafael D; Videira M; Ferreira D; Sosnik A; Sarmento B
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1816-27. PubMed ID: 23932923
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Medicinal Chemistry--XVth EFMC International Symposium. New technologies in drug discovery. 6-10 September 1998, Edinburgh, Scotland, UK.
    Buckle DR
    IDrugs; 1998 Dec; 1(8):860-2. PubMed ID: 16196472
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Novel 1H-1,2,3-, 2H-1,2,3-, 1H-1,2,4- and 4H-1,2,4-triazole derivatives: a patent review (2008 - 2011).
    Ferreira VF; da Rocha DR; da Silva FC; Ferreira PG; Boechat NA; Magalhães JL
    Expert Opin Ther Pat; 2013 Mar; 23(3):319-31. PubMed ID: 23289412
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Antimicrobial resistance: A multifaceted problem with multipronged solutions.
    Gil-Gil T; Laborda P; Sanz-García F; Hernando-Amado S; Blanco P; Martínez JL
    Microbiologyopen; 2019 Nov; 8(11):e945. PubMed ID: 31724836
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [JSPS Asia and Africa scientific platform program development for the medicinal chemistry based on biologically active natural products in the subtropical zone].
    Saito N; Morita T
    Yakugaku Zasshi; 2009 Apr; 129(4):407-12. PubMed ID: 19336994
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Fighting infection: an ongoing challenge, part 1.
    Turkoski BB
    Orthop Nurs; 2005; 24(1):40-6; quiz 47-8. PubMed ID: 15722973
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Robin Ganellin gives his views on medicinal chemistry and drug discovery. Interview by Stephen L. Carney.
    Ganellin CR
    Drug Discov Today; 2004 Feb; 9(4):158-60. PubMed ID: 14960393
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Medical implications of benzimidazole derivatives as drugs designed for targeting DNA and DNA associated processes.
    Bhattacharya S; Chaudhuri P
    Curr Med Chem; 2008; 15(18):1762-77. PubMed ID: 18691037
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Progress and dilemma of contemporary clinical pharmacology.
    Herman ZS
    Int J Clin Pharmacol Ther; 2005 Jan; 43(1):43-50. PubMed ID: 15704614
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Amarogentin as Topical Anticancer and Anti-Infective Potential: Scope of Lipid Based Vesicular in its Effective Delivery.
    Patel K; Kumar V; Verma A; Rahman M; Patel DK
    Recent Pat Antiinfect Drug Discov; 2019; 14(1):7-15. PubMed ID: 30210007
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Health security preparedness and industry trends.
    Crooke ST
    Health Secur; 2015; 13(2):74-81. PubMed ID: 25813972
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Hydroids (Cnidaria, Hydrozoa) from Mauritanian Coral Mounds.
    Gil M; Ramil F; AgÍs JA
    Zootaxa; 2020 Nov; 4878(3):zootaxa.4878.3.2. PubMed ID: 33311142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.